Papapetropoulos Spyros 4
4 · Lipocine Inc. · Filed Jun 10, 2022
Insider Transaction Report
Form 4
Lipocine Inc.LPCN
Papapetropoulos Spyros
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-08$0.92/sh+22,000$20,240→ 32,000 totalExercise: $0.92From: 2023-06-08Exp: 2032-06-08→ Common Stock (22,000 underlying)
Footnotes (1)
- [F1]Subject to vesting whereby all of the shares subject to the award will vest on the one year anniversary of June 8, 2023.